In a 38-year-old man with a history of unprovoked pulmonary embolism, does he need an echocardiogram with an agitated-saline bubble study?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Echocardiogram with Bubble Study Not Routinely Indicated for Stable Unprovoked PE

For a 38-year-old man with a history of unprovoked pulmonary embolism who is clinically stable, routine echocardiography with bubble study is not indicated unless he had massive or submassive PE at presentation, or if there are specific clinical concerns for paradoxical embolism or intracardiac shunt.

Risk Stratification Determines Need for PFO Screening

The decision to perform bubble study echocardiography hinges on the severity of the original PE event and current clinical status:

When Bubble Study May Be Considered (Class IIb)

According to the 2011 AHA Scientific Statement, screening for patent foramen ovale (PFO) with agitated saline bubble study may be considered only in patients with massive or submassive PE for risk stratification 1. This is a weak recommendation (Class IIb, Level of Evidence C), meaning it's optional even in these higher-risk scenarios.

The rationale is that PFO presence in massive PE patients increases:

  • Risk of death (relative risk 2.4)
  • Ischemic stroke risk (relative risk 5.9)
  • Peripheral arterial embolism (relative risk 15)
  • Complicated hospital course (relative risk 5.2) 1

When Bubble Study Is NOT Indicated

For patients with:

  • Low-risk or stable PE (which describes most unprovoked PE cases in young, otherwise healthy patients)
  • No hemodynamic instability at presentation
  • No history of stroke or paradoxical embolism
  • Completed acute phase of treatment

There is no guideline support for routine PFO screening 1.

Clinical Context Matters

Define the Original PE Severity

You need to clarify whether this patient's unprovoked PE was:

  • Massive PE: Hemodynamic instability (cardiac arrest, obstructive shock, persistent hypotension <90 mmHg)
  • Submassive PE: Right ventricular dysfunction on imaging or elevated cardiac biomarkers without hemodynamic collapse
  • Low-risk PE: Hemodynamically stable with normal or near-normal right ventricular function

Current Clinical Scenario

If this question arises because:

Scenario 1: Routine follow-up after stable PE

  • No bubble study needed
  • Focus on anticoagulation duration decisions and recurrence prevention

Scenario 2: New neurological symptoms or cryptogenic stroke

  • Bubble study becomes appropriate to evaluate for paradoxical embolism as stroke mechanism 2
  • This shifts from PE management to stroke workup

Scenario 3: Severe refractory hypoxemia during acute PE

  • Bubble study indicated to diagnose right-to-left shunt contributing to hypoxemia 3
  • Can guide aggressive therapy decisions

Evidence Limitations and Practical Considerations

The 2011 AHA guidelines explicitly acknowledge that key questions remain unanswered 1:

  • How to screen for PFO in PE patients
  • How PFO presence should change PE management
  • When to consider PFO closure in patients with PE
  • How PFO shunt size influences adverse events

These questions remain unresolved in 2026, as the most recent PE guidelines 4 do not provide updated recommendations on routine PFO screening in stable PE patients.

Common Pitfalls to Avoid

  1. Don't order bubble study reflexively for all PE patients—it's not standard of care
  2. Don't confuse diagnostic echocardiography (to assess RV function during acute PE) with bubble study (to detect intracardiac shunt)
  3. Timing matters: Bubble study showing bubbles appearing after 3-6 cardiac cycles suggests intrapulmonary shunt rather than intracardiac shunt 5
  4. Alternative indication: If considering this for anticoagulation duration decisions, PFO status doesn't change standard unprovoked PE anticoagulation recommendations

Bottom Line Algorithm

Unprovoked PE patient → Was it massive/submassive at presentation?
├─ YES → Bubble study may be considered (Class IIb) [1]
└─ NO (stable/low-risk) → No routine bubble study indicated
    └─ Exception: New stroke/TIA → Bubble study for paradoxical embolism workup [2]

For your 38-year-old with unprovoked PE, unless he presented with hemodynamic compromise or RV dysfunction, no bubble study is needed 1.

References

2
Research

Guidelines for the Use of Echocardiography in the Evaluation of a Cardiac Source of Embolism.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2016

3
Research

Severe Hypoxemia in Acute Pulmonary Embolism.

Respirology case reports, 2025

Related Questions

When should a bedside transthoracic echocardiogram be ordered for a patient with bilateral pulmonary emboli?
What admission orders should be placed for a patient with pulmonary embolism?
What are the 2026 guidelines for the management of pulmonary embolism?
In a 38-year-old woman with persistent dyspnea four months after an acute pulmonary embolism treated with three months of anticoagulation, which test should be ordered next: a 6‑minute walk test, CT pulmonary angiography, ventilation‑perfusion (V/Q) lung scan, or pulmonary angiography?
What is the appropriate management of acute pulmonary embolism?
When should a cardiac event monitor be ordered instead of continuous outpatient monitoring for a patient?
In a patient with urinary retention, which antipsychotic medication is most appropriate?
What are the recommended dosing regimens for prazosin for hypertension, benign prostatic hyperplasia (BPH), and post‑traumatic stress disorder (PTSD), including starting dose, titration schedule, and maximum daily dose?
In a patient recently discharged who is taking apixaban 5 mg twice daily for unspecified atrial fibrillation and now presents with left arm swelling, redness, and bruising, what is the appropriate management?
What is the appropriate starting dose of bupropion (sustained‑release) for an adult patient?
What are the appropriate treatments for a non‑healing venous ulcer without infection or arterial insufficiency?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.